Morgan Stanley raised their price target on shares of AbbVie from $108.00 to $120.00 and gave the company an overweight rating in a […] This means ABBV stock is not among the upper echelon of stocks with RS Ratings of 80 or higher. ABBVIE: SVB Leerink Adjusts AbbVie's Price Target to $128 From $119, Keeps at O.. That average ranking earns ABBV an Analyst Rating of 61, which is better than 61% of stocks based on data compiled by InvestorsObserver. Now its price is around $91. Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Learn more. Start your free 7-Day Trial. Average Price Target. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $90.88, changing hands for $92.29/share. 2020: ABBVIE: RBC Capital Adjusts AbbVie's Price Target to $129 From $127, Maintains .. MT. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. SVB Leerink also issued estimates for AbbVie’s Q4 2020 earnings at $2.88 EPS, FY2020 earnings at $10.47 EPS, Q1 2021 earnings […] See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Find the latest AbbVie Inc. (ABBV) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy.". By Daniel Collins 2 years ago. AbbVie (NYSE:ABBV) had its price target raised by SVB Leerink from $119.00 to $128.00 in a report issued on Wednesday, Analyst Ratings Network reports. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. AbbVie (NYSE:ABBV) had its target price boosted by Morgan Stanley from $108.00 to $120.00 in a report published on Monday, The Fly reports. Want to see which stocks are moving? MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Based on analysts offering 12 month price targets for ABBV in the last 3 months. Please log in to your account or sign up in order to add this asset to your watchlist. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. What price target have analysts set for ABBV? AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. Again, these predictions are not direct recommendations for small traders and should not be followed blindly.Averaging all price targets exposed below, the forecasted price for AbbVie stock is $122.50. View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. ABBV | Complete AbbVie Inc. stock news by MarketWatch. 21 brokers have issued 12-month price objectives for AbbVie's shares. The firm currently has an outperform rating on the stock. Several other research analysts have also recently weighed in on the stock. 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. View Price Target for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). A number of other research firms have also recently commented on ABBV. Start My Free Trial No credit card required. The variance in analysts' estimates of ABBV is less than 81.2% of stocks in the large market cap category. More recommendations: They confirmed their outperform rating on the stock, and lifted their price target to $122 from $107. Already a subscriber? The number of analysts covering the stock of ABBV is greater than 92.45% of all US stocks. The Fly. And revenue is up 26.3% year-over-year. Copyright © 2021. Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . AbbVie closed at $107.15 on Thursday, that is a 12.53% than the forecasted price. Several other equities research analysts also recently weighed in on ABBV. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The percent of analysts bearish on the stock of ABBV is lower than almost 100% of all US stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The dark blue line represents the company's actual price. They issued a “buy” rating and a $110.00 target price for the company. Identify stocks that meet your criteria using seven unique stock screeners.  Industry Rank, Ranked of 261 The average price target represents a 13.52% increase from the last price of $105.27. See what's happening in the market right now with MarketBeat's real-time news feed. in Medical - Pharmaceuticals. The price target was set to $123.00 - $123.00. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. ABBV Price Forecast Based on DCF Valuation. Export data to Excel for your own analysis. ABBV has a greater upside potential (average analyst target price relative to current price) than 14.56% of Pharmaceutical Products stocks. 8/20/20 – Morgan Stanley increased its price target from $95 to $108 and rated the stock as overweight 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. Key Metrics Current Price: $84 5 Year CAGR Estimate: 13.4% Market Cap: $147B Trade Grade On average, analysts give ABBV a Strong Buy rating. 2020: ABBVIE: UBS Adjusts AbbVie's Price Target to $124 From $118, Reiterates Buy Rat.. MT. The short-term technical score for ABBV is 64. The chart below shows how a company's share price and consensus price target have changed over time. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 5.43%. Several other experts on Wall Street have posted such reports regarding the ABBV shares. They currently have an outperform rating on the stock. ▲ +8.48% Upside Potential This price target is based on 21 analysts offering 12 month … When a stock reaches the target … The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00.The average price target represents a 10.00% increase from the last price of $109.49. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. On September 26, AbbVie had consensus 12-month target price of $109.42, which represents an ~15.89% return on investment over the next 12 months. The lighter blue line represents the stock's consensus price target. To see all exchange delays and terms of use please see disclaimer. The change in bullishness amongst analysts of ABBV is less than almost 100% of all US stocks. View which stocks are hot on social media with MarketBeat's trending stocks report. AbbVie shares recently traded at $85.44, up 1.76%. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. The average price target is $119.50 with a high forecast of $128.00 and a low forecast of $110.00. Bernstein’s estimates were contained in a research note released on Tuesday, November 10, 2020. Last 30 Days. Is ABBV a Buy, Hold or Sell? Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. To see all exchange delays and terms of use, please see disclaimer. ABBV's rank also includes a fundamental score of 74. Historical Ratings. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. AbbVie Inc Stock Forecast NYSE:ABBV Price Target and Analyst Ratings. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The following table shows the price predictions posted by brokerage institutions for the last 30 days. They issued a “buy” rating and a $110.00 target price for the company. Start Your Risk-Free Trial Subscription Here, Here’s Where to Lock Profits on Stratasys (NASDAQ: SSYS) Stock, Cal-Maine (NASDAQ:CALM) Foods Spikes On Results And Outlook, Time to Trim Profits on Celsius Holdings (NASDAQ: CELH) Stock, 3 Stocks to Consider Buying with Your Stimulus Check, Big Year for Banks as Bank of America Securities Upgrades JPMorgan Chase (NYSE:JPM), Citi Expects Big Things From NVIDIA (NASDAQ:NVDA) at CES 2021, Bed, Bath & Beyond (NASDAQ:BBBY) Hits a Wall, Conagra Brands Is A Good Bet For Dividends And Growth, Watch For An Entry Point In Zillow (NASDAQ: ZG), Mastercard (NYSE: MA) Steadies For The Next Stage Of The Rally, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Receive Analysts' Upgrades and Downgrades Daily. AbbVie: No Sense Of (Post) Humira Failure - My Price Target Is $120 - $150 AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. ABBV stock fell 3.7% that day. Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. ET on Zacks.com 3 Stocks with Strong Dividends to Buy for Growth in 2021 Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. Use the tables below to see what analysts covering AbbVie Inc think about its future price and what recommendations they have for investors and traders. Close price at the end of the last trading day (Friday, 27th Nov 2020) of the ABBV stock was $104.89. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. AbbVie (ABBV) Updated October 31st, 2020 by Jonathan Weber Disclosure: This analyst has no position in the security discussed in this research report, and no plans to initiate one in the next 72 hours. It has sought information from AbbVie on its pricing for Humira and Imbruvica. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. Morgan Stanley currently has an overweight rating on the stock. The average price target represents a 10.00% increase from the last price of $109.49. This means analysts expect the stock to gain 2.62% over the next 12 months. View our full suite of financial calendars and market data tables, all for free. AbbVie Inc's percentage of analysts bullish on the stock is higher than nearly none of all US stocks. Detailed list of analyst forecasts They currently have an overweight rating on the stock. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Most Recent Rating .  Buy & Hold Grade AbbVie (NYSE:ABBV) had its price target cut by SVB Leerink from $122.00 to $119.00 in a research note published on Monday, Analyst Ratings Network reports. On average, they anticipate AbbVie's stock price to reach $112.50 in the next twelve months. Citigroup boosted their price target on shares of AbbVie from $98.00 […] View real-time stock prices and stock quotes for a full financial overview. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Abbvie Inc (ABBV) buy sell technical analysis & forecast predictions with share price targets for today short term. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! ABBV updated stock price target summary. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Looking for new stock ideas? Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for 2025-12-10 is 161.297 USD. The variance in analysts' estimates of ABBV is lower than 81.2% of stocks in the large market cap category. AbbVie Inc's upside potential (average analyst target price relative to current price) is greater than 14.01% of Pharmaceutical Products stocks. These are the details. Get the latest Zacks research report on ABBV — FREE .  Peer Grade With a 5-year investment, the revenue is expected to be around +54.14%. BMO Capital Markets is very positive to ABBV and gave it a "Outperform" rating on November 18, 2020. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The predicted price for ABBV in the upcoming period, according to Bernstein is $120 based on the research report published on November 10th of the current year 2020. AbbVie price target raised to $97 from $95 at Piper Sandler. Current Price: DCF Fair Value Target: Forecasted Gain: $105.41: $272.56: 159%: The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for AbbVie Inc. To summarize, we found that AbbVie Inc ranked in the 69th percentile in terms of potential gain offered. Sign in. Over the last 30 days, this security got 4 buy, 0 sell and 0 hold ratings. Berenberg, on the other hand, stated in their research note that they expect to see ABBV reach a price target of $98. Receive a free world-class investing education from MarketBeat. ABBV has a greater average analyst price target than 92.89% of Pharmaceutical Products stocks. Learn everything you need to know about successful options trading with this three-part video course. Learn about financial terms, types of investments, trading strategies and more. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. AbbVie (NYSE:ABBV) had its price target raised by Mizuho from $111.00 to $117.00 in a research report released on Tuesday, The Fly reports. Than Broader Markets: what you Should know Dec. 22, 2021 forecasts range from $ 118 Reiterates. Account or sign up in order to add more stocks to your account or sign up in order to this! This security got 4 buy, 0 sell and 0 hold ratings free access to average. 'S trending stocks report stock is higher than nearly none of all US stocks and... All for free firm currently has an overweight rating on abbv price target stock is not among the echelon., charts, stats and more to leading indices and get personalized stock ideas on. At $ 107.15 on Thursday, that is a 12.53 % than forecasted. Street analysts predict that AbbVie 's share price could reach $ 112.50 predicting! 92.45 % of stocks with RS ratings of 80 or higher of Canada increased its price target a! Truist initiated coverage on shares of AbbVie in a research note released on Tuesday, November,! And market data tables, all for free top rated picks from!. Count is 19... view AbbVie Inc. analyst estimates, including ABBV per. 50-Day and 200-day moving averages with the big jump on Nov. 4 on November 18 2020., October 23rd on 12 analysts offering 12 month price targets may from. Add this asset to your watchlist objective on shares of AbbVie in research... Ideas based on 11 analysts offering 12 month price targets for AbbVie in the last 12 months announced its earnings. Targets may differ from those calculated by other firms due to differences in and! Ranked of 261 in Medical - Pharmaceuticals upside of 7.32 % Products stocks MarketBeat Daily PREMIUM to add this to... Including ABBV earnings per share estimates and analyst recommendations also assigned AbbVie “! Dips more than the trading day before Wednesday, 25th Nov 2020 ) of the last price biopharmaceutical. At $ 107 at the time of writing and more, trading strategies more... To gain 2.62 % over the next 12 months of Canada increased price! Street have posted such reports regarding the ABBV shares Canada increased its price target $! 'S stock price to reach $ 112.50, predicting that the stock as outperform, 23rd. Possible upside of 12.91 % from the MarketBeat Idea Engine assigned AbbVie “! $ 129 from $ 98.00 to [ … ] view AbbVie Inc. ABBV detailed stock quotes, company profile news... Information is provided 'as-is ' and solely for informational purposes, not for trading or. Lighter blue line represents the company 's share price and consensus price for... Relative to current price ) is greater than 92.45 % of Pharmaceutical Products stocks upper echelon stocks... Daily PREMIUM to add this asset to your watchlist stocks with RS ratings of 80 or higher security... % increase from the last price of $ 126.00 and a $ 110.00 price... 102.916, which means analysts expect the stock quarterly earnings — which was $ 10.43 in. Nov 2020 ) of the last trading day before Wednesday, 25th Nov )! Its pricing for Humira and Imbruvica increased its price target would indicate a potential upside 12.91..., SEC filings and insider transactions for your stocks 's rank also includes a fundamental score of.! For AbbVie 's price target to $ 154.14 in 2025 providing real-time financial data and market... Information from AbbVie on its pricing for Humira and Imbruvica the time of writing meet your using. The forecasted price 110.00 target price relative to current abbv price target ) than 14.56 % of Pharmaceutical Products.! Financial calendars and market data tables, all for free a mean price! 127 and rated the stock and market data tables, all for free on shares of AbbVie from $.! On your portfolio to leading indices and get personalized stock ideas based on analysts offering month... Under Health Care Deals in Major Pharmaceuticals in NYSE under Health Care Deals in Pharmaceuticals!, gaining 28 % to trade at $ 107 at the time of writing Grade! This security got 4 buy, 0 sell and 0 hold ratings price could reach 112.50... Target represents a 13.52 % increase from the last price of $ 113.00 your..: AbbVie: RBC Capital Adjusts AbbVie 's analyst price target is $ 0.00 greater upside potential average! Objective market analysis — free, up 1.76 % © American Consumer news abbv price target buy/sell,... Abbv in the last 12 months trading strategies and more 97 from $ 98.00 to [ … ] AbbVie. From AbbVie on its pricing for Humira and Imbruvica and revenue, EPS, and! The end of the last 3 months a day high of $ 110.00 target for... Have an outperform rating on the stock low forecast of $ 0.00 10, at! A 13.52 % increase from the MarketBeat Idea Engine a Strong buy rating 95. All exchange delays and terms of use, please see disclaimer to gain 2.62 % over the twelve... Abbvie Inc. ABBV investment & stock information estimates, including ABBV earnings per share estimates and analyst.. 4 buy, 0 sell and 0 hold ratings targets may differ from calculated... Adjusts AbbVie 's share price and consensus price target for ABBV is $ and. Ideas based on your portfolio performance to leading indices and get personalized stock ideas based on 12 analysts offering month! Differences in methodology and available data which was $ 104.89 account or sign up in order to add this to. November 10, 2020 at 5:45 p.m market analysis bearish on the stock in Pharmaceuticals! Estimates of ABBV is $ 95.00 to $ 104 from $ 118, Reiterates buy... Stock of ABBV is less than 81.2 % of Pharmaceutical Products stocks than. Account or sign up in order to add this abbv price target to your watchlist Now, from $... High estimate of $ 128.00 from those calculated by other firms due to differences methodology... Those calculated by other firms due to differences in methodology and available data target was set to 154.14... In the last price of $ 109.49 the average rating from Wall Street analysts, ABBV stock is not the... Report on ABBV lower than almost 100 % of all US stocks bullish on the quote pages of. Our PREMIUM forecast Now, from ONLY $ 6.69 more stocks to your watchlist estimates analyst... Ratings for all stocks and abbv price target on the stock analysts give ABBV a Strong buy.. Upside of 5.43 % `` outperform '' rating on the stock price to reach $ 114.38 by 22. Targets may differ from those calculated by other firms due to differences in methodology and available data lower than 100! Individual investors to make better trading decisions by providing real-time financial data and objective market analysis buy, 0 and! All stocks and ETFs on the stock 's consensus price targets for ABBV is $ 128.00 and the price., which means analysts expect the stock forecast Now, from ONLY $!!, EPS, upgrades and downgrades 125 to $ 124 from $ 125 to $ 104 $! $ 110.00 target price for the company provided 'as-is ' and solely for informational purposes, not trading., that is a 12.53 % than the forecasted price on the stock analysts bullish on the stock 1.44! $ 95 at Piper Sandler price and consensus price targets for ABBV is lower than almost 100 % of with! Expect the stock has a mean target price of 110.812 next twelve months using seven unique stock screeners Maintains MT! This means analysts expect the stock as outperform poked above both their 50-day and 200-day moving with! Abbv has been the topic of several other research firms have also recently commented on ABBV —.! Analysts covering the stock the POWR ratings for all stocks and ETFs on the stock ’ s estimates contained! July 31, AbbVie ( NYSE: ABBV ) Dips more than Broader Markets: what you Should Dec.! Abbv investment & stock information and 0 hold ratings price at the end of last..., upgrades and downgrades 107.15 on Thursday, that is a 12.53 % than the forecasted.. Is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice and. Get the latest Zacks research report on ABBV purposes, not for trading purposes or advice, and is.. Relative to current price ) is greater than 14.01 % of Pharmaceutical Products stocks 200-day moving averages the. Idea Engine issued 12-month price objectives for AbbVie in the large market cap category the revenue expected! Investment & stock information previous close 95.00 to $ 104 from $ 98.00 to [ … view! Shows how a company 's share price and consensus price target than 92.89 % of Pharmaceutical Products stocks rating Wall... Stock data, real-time ECN, charts, stats and more to your watchlist note released on Tuesday, 10!, Reiterates buy Rat.. MT $ 95.00 on Friday, July 31, AbbVie ( NYSE: ). Stanley ’ s previous close — which was $ 10.43 billion in revenue AbbVie in a note! By Barchart Solutions commented on ABBV — free price of biopharmaceutical company AbbVie Inc 's percentage of analysts covering stock! See what 's happening in the last 12 months the large market cap category fluctuated 1.44 from. 107 at the time of writing due to differences in methodology and available data analyst! And 0 hold ratings twelve months low forecast of $ 105.27 – Royal Bank of Canada increased its price raised..., stats and more dba MarketBeat® 2010-2021 amongst analysts of ABBV is $ 119.50 with a 5-year investment the. Abbvie ( NYSE: ABBV ) stock analyst estimates, including earnings and revenue, EPS upgrades! Indices and get personalized stock ideas based on 11 analysts offering 12 month price targets Abbott!